Breakdown | TTM | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
---|---|---|---|---|---|---|
Income Statement | ||||||
Total Revenue | 70.29B | 71.42B | 68.01B | 64.82B | 69.07B | 67.44B |
Gross Profit | 15.05B | 15.02B | 15.41B | 14.09B | 15.05B | 14.73B |
EBITDA | 6.14B | 7.99B | 10.88B | 6.98B | 8.75B | 7.81B |
Net Income | 2.55B | 3.23B | 5.38B | 2.59B | 3.67B | 3.13B |
Balance Sheet | ||||||
Total Assets | 62.86B | 63.52B | 64.44B | 61.62B | 59.79B | 61.61B |
Cash, Cash Equivalents and Short-Term Investments | 23.11B | 18.20B | 25.28B | 18.36B | 18.62B | 17.26B |
Total Debt | 3.88B | 3.45B | 4.75B | 5.93B | 8.11B | 10.34B |
Total Liabilities | 22.23B | 21.49B | 24.67B | 24.26B | 26.36B | 30.19B |
Stockholders Equity | 38.08B | 39.41B | 37.28B | 34.98B | 31.19B | 29.41B |
Cash Flow | ||||||
Free Cash Flow | 0.00 | 851.64M | 2.98B | 3.40B | 5.21B | 2.00B |
Operating Cash Flow | 0.00 | 2.94B | 5.31B | 4.99B | 6.83B | 6.84B |
Investing Cash Flow | 0.00 | -2.90B | 6.33B | -788.01M | -2.03B | -4.44B |
Financing Cash Flow | 0.00 | -3.16B | -2.87B | -3.46B | -3.58B | -664.82M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
77 Outperform | ¥14.11B | 19.94 | 2.99% | 11.76% | 9.90% | ||
71 Outperform | ¥255.65B | 12.96 | 8.49% | 3.09% | 6.31% | 12.94% | |
69 Neutral | ¥32.65B | 10.08 | 2.68% | 5.01% | -39.78% | ||
$15.91B | 21.03 | 8.55% | 1.86% | ― | ― | ||
72 Outperform | ¥3.60B | 13.11 | 3.62% | 13.49% | 17.08% | ||
66 Neutral | ¥512.96B | 18.18 | 0.20% | 5.85% | 4.84% | ||
65 Neutral | ¥8.78B | 58.08 | ― | 13.52% | -45.02% |